Herbert J. Zeh III

  • 16389 Citations
  • 66 h-Index
1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Herbert J. Zeh III is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Assessment of response to neoadjuvant therapy using CT texture analysis in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma

Borhani, A. A., Dewan, R., Furlan, A., Seiser, N., Zureikat, A. H., Singhi, A. D., Boone, B., Bahary, N., Hogg, M. E., Lotze, M., Zeh, H. J. & Tublin, M. E., Jan 1 2020, In : American Journal of Roentgenology. 214, 2, p. 362-369 8 p.

Research output: Contribution to journalArticle

  • Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein

    Dai, E., Han, L., Liu, J., Xie, Y., Kroemer, G., Klionsky, D. J., Zeh, H. J., Kang, R., Wang, J. & Tang, D., Jan 1 2020, (Accepted/In press) In : Autophagy.

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer

    Liu, H., Zenati, M. S., Rieser, C. J., Al-Abbas, A., Lee, K. K., Singhi, A. D., Bahary, N., Hogg, M. E., Zeh, H. J. & Zureikat, A. H., Jan 1 2020, (Accepted/In press) In : Annals of Surgical Oncology.

    Research output: Contribution to journalArticle

  • Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States

    Ordonez, J. E., Hester, C. A., Zhu, H., Augustine, M., Porembka, M. R., Wang, S. C., Yopp, A. C., Mansour, J. C., Zeh, H. J. & Polanco, P. M., Jan 1 2020, (Accepted/In press) In : Annals of Surgical Oncology. 27, 6, p. 1997-2006 10 p.

    Research output: Contribution to journalArticle

  • Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma (Annals of Surgical Oncology, (2020), 10.1245/s10434-019-08156-3)

    Al Abbas, A. I., Zenati, M., Rieser, C. J., Hamad, A., Jung, J. P., Zureikat, A. H., Zeh, H. J. & Hogg, M. E., Jan 1 2020, (Accepted/In press) In : Annals of Surgical Oncology.

    Research output: Contribution to journalComment/debate

    Open Access